Review
doi: 10.3109/10739689709148314.
The Eugene M. Landis Award Lecture 1996. Delivery of molecular and cellular medicine to solid tumors
Affiliations
- PMID: 9110280
- DOI: 10.3109/10739689709148314
Item in Clipboard
Review
The Eugene M. Landis Award Lecture 1996. Delivery of molecular and cellular medicine to solid tumors
Microcirculation.
1997 Mar.
Abstract
To reach cancer cells in a tumor, a blood-borne therapeutic molecule or cell must make its way into the blood vessels of the tumor and across the vessel wall into the interstitium and finally migrate through the interstitium. Unfortunately, tumors often develop in ways that hinder each of these steps. Our research goals are to analyze each of these steps experimentally and theoretically and then integrate the resulting information in a unified theoretical framework. This paradigm of analysis and synthesis has allowed us to obtain a better understanding of physiologic barriers in solid tumors and to develop novel strategies to exploit and/or to overcome these barriers for improved cancer detection and treatment.
Similar articles
-
1995 Whitaker Lecture: delivery of molecules, particles, and cells to solid tumors.Ann Biomed Eng. 1996 Jul-Aug;24(4):457-73. doi: 10.1007/BF02648108. Ann Biomed Eng. 1996. PMID: 8841721 Review.
-
Delivery of molecular and cellular medicine to solid tumors.J Control Release. 1998 Apr 30;53(1-3):49-67. doi: 10.1016/s0168-3659(97)00237-x. J Control Release. 1998. PMID: 9741913 Review.
-
Delivery of molecular and cellular medicine to solid tumors.Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):149-68. doi: 10.1016/s0169-409x(00)00131-9. Adv Drug Deliv Rev. 2001. PMID: 11259838 Review.
-
Delivery of molecular and cellular medicine to solid tumors.Adv Drug Deliv Rev. 2012 Dec 1;64(Suppl):353-365. doi: 10.1016/j.addr.2012.09.011. Adv Drug Deliv Rev. 2012. PMID: 24511174 Free PMC article.
-
Delivery of molecular and cellular medicine to solid tumors.Adv Drug Deliv Rev. 1997 Jul 7;26(2-3):71-90. doi: 10.1016/s0169-409x(97)00027-6. Adv Drug Deliv Rev. 1997. PMID: 10837535
Cited by
-
A mouse model study of toxicity and biodistribution of a replication defective adenovirus serotype 5 virus with its genome engineered to contain a decoy hyper binding site to sequester and suppress oncogenic HMGA1 as a new cancer treatment therapy.PLoS One. 2018 Feb 20;13(2):e0192882. doi: 10.1371/journal.pone.0192882. eCollection 2018. PLoS One. 2018. PMID: 29462157 Free PMC article.
-
Discovery of targeting ligands for breast cancer cells using the one-bead one-compound combinatorial method.J Med Chem. 2009 Jan 8;52(1):126-33. doi: 10.1021/jm801062d. J Med Chem. 2009. PMID: 19055415 Free PMC article.
-
Characterisation of systemic dissemination of nonreplicating adenoviral vectors from tumours in local gene delivery.Br J Cancer. 2005 Apr 25;92(8):1414-20. doi: 10.1038/sj.bjc.6602494. Br J Cancer. 2005. PMID: 15812558 Free PMC article.
-
Penetration and intracellular uptake of poly(glycerol-adipate) nanoparticles into three-dimensional brain tumour cell culture models.Exp Biol Med (Maywood). 2016 Mar;241(5):466-77. doi: 10.1177/1535370215610441. Epub 2015 Nov 13. Exp Biol Med (Maywood). 2016. PMID: 26568330 Free PMC article.
-
Biodistribution mechanisms of therapeutic monoclonal antibodies in health and disease.AAPS J. 2010 Mar;12(1):33-43. doi: 10.1208/s12248-009-9157-5. Epub 2009 Nov 19. AAPS J. 2010. PMID: 19924542 Free PMC article. Review.
Publication types
MeSH terms
Personal name as subject
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
